Markel (MKL): Berkshire Hathaway Reincarnated?

Markel (MKL): Berkshire Hathaway Reincarnated?

CEO Tom Gayner’s Markel Group (NYSE: $MKL) is called a “Baby Berkshire” for its similarities to Warren Buffett’s Berkshire Hathaway: Stellar investing returns made using an insurance company’s float – and made across investments in public and private markets. High-effort annual meetings that engender tribes of long-term shareholders. But is $21-billion-market-cap Markel (Berkshire’s market cap is nearly $900 billion) really an alternative to Berkshire Hathaway? Might it offer higher upside for investors? Or not? BBAE CIO James Early and analyst Shaoping Huang attended the Markel “Reunion” in Richmond, Virginia and shared their thoughts afterward. 
Click here or on the image below to watch.

This article is for informational purposes only and is neither investment advice nor a solicitation to buy or sell securities. All investment involves inherent risks, including the total loss of principal, and past performance is not a guarantee of future results. Always conduct thorough research or consult with a financial expert before making any investment decisions. James owns shares of Markel and Berkshire Hathaway. BBAE has no position in any investment mentioned.

Related Posts
BBAE Blueprint

Join BBAE: Unlock Up to $400 Bonus!

Tailored insights, powerful tools. Automatic bonus at signup.
Get Started with BBAE Now!